Patents matching “chemotherapy”

US 8034334

Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2011 · Expires Oct 6, 2031

US 7815921

Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy

Ludwig-Maximilians-Universitat Munchen · Granted Oct 19, 2010 · Expires Oct 14, 2030

US 7037904

Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for suppressing side-effect of radiotherapy and chemotherapy

Third Military Medical University, Chinese People's Liberation Army, P.R. of China · Granted May 2, 2006 · Expires Apr 27, 2026

US 7008633

Local regional chemotherapy and radiotherapy using in situ hydrogel

The Board of Regents of the University of Texas System · Granted Mar 7, 2006 · Expires Mar 2, 2026

US 7005424

Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy

The Board of Regents of the University of Texas System · Granted Feb 28, 2006 · Expires Feb 23, 2026

US 6863885

Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 8, 2005 · Expires Mar 3, 2025

US 6653351

Adjuvant chemotherapy for anaplastic gliomas

The Board of Regents of the University of Texas System · Granted Nov 25, 2003 · Expires Nov 20, 2023

US 6426076

Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemotherapy and radiotherapy

PASCO Pharmazeutische Präparate GmbH · Granted Jul 30, 2002 · Expires Jul 25, 2022

US 6423311

Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment

The United States of America, as represented by the Department of Health and Human Services · Granted Jul 23, 2002 · Expires Jul 18, 2022

US 6395712

Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy

The Board of Regents of the University of Texas System · Granted May 28, 2002 · Expires May 23, 2022

US 6261831

Ultra-wide band RF-enhanced chemotherapy for cancer treatmeat

United States of America as represented by the Secretary of the Air Force · Granted Jul 17, 2001 · Expires Jul 12, 2021

US 6103694

Method of decreasing radiation of radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 15, 2000 · Expires Aug 10, 2020